Stockscreener 앱 받기
1.05
10.38%
0.0987
전일 마감가:
$0.9513
열려 있는:
$0.9513
하루 거래량:
190.57K
Relative Volume:
0.52
시가총액:
$44.84M
수익:
$24.38M
순이익/손실:
$-53.95M
주가수익비율:
-0.4251
EPS:
-2.47
순현금흐름:
$-23.31M
1주 성능:
+6.37%
1개월 성능:
+19.89%
6개월 성능:
-51.39%
1년 성능:
-63.29%
1일 변동 폭
$0.9513
$1.12
1주일 범위
$0.8507
$1.12
52주 변동 폭
$0.50
$3.46
Elutia Inc Stock (ELUT) Company Profile
명칭
Elutia Inc
전화
240-247-1143
주소
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
1.05 | 40.62M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-11-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-11-02 | 개시 | Cowen | Outperform |
| 2020-11-02 | 개시 | Piper Sandler | Overweight |
| 2020-11-02 | 개시 | Truist | Buy |
Elutia Inc 주식(ELUT)의 최신 뉴스
Short Covering: Is Elutia Inc benefiting from innovation trendsJuly 2025 Big Picture & Community Verified Trade Signals - baoquankhu1.vn
What is Elutia Inc. s debt to equity ratioJuly 2025 Closing Moves & Safe Capital Growth Plans - mfd.ru
CEO Moves: Is Elutia Inc benefiting from innovation trendsInsider Selling & Real-Time Volume Spike Alerts - baoquankhu1.vn
Options Flow: Can Elutia Inc be recession proofPrice Action & Technical Confirmation Alerts - baoquankhu1.vn
Elutia Loses US$4.6m Market Value But Insiders See Windfall Of US$60k - simplywall.st
Insider Spends US$74k Buying More Shares In Elutia - Yahoo Finance
Aug Summary: What is the Moat Score of Elutia IncStop Loss & Smart Allocation Stock Tips - baoquankhu1.vn
Trend Report: Is Elutia Inc forming a breakout patternJuly 2025 Technicals & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
ELUTIA INC (ELUT) Upgraded to Buy: Here's What You Should Know - sharewise.com
Insider Buying: Guido Neels Acquires 20,000 Shares of Elutia Inc (ELUT) - GuruFocus
Elutia Inc. director Neels buys $20,800 in shares By Investing.com - Investing.com Australia
Elutia Inc. director Neels buys $20,800 in shares - Investing.com
Elutia launches $15M securities offering - MSN
Elutia Inc: director Neels buys $31.8k in company stock By Investing.com - Investing.com South Africa
Insider Buying: Guido Neels Acquires 30,000 Shares of Elutia Inc (ELUT) - GuruFocus
Elutia Inc: director Neels buys $31.8k in company stock - Investing.com
Aug Movers: Can OPCH scale operations efficientlyMarket Performance Report & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Elutia sees Q4 net sales of $3.3M - MSN
Plus Therapeutics Spurs After-Hours Biotech Rally; Connect Biopharma And Elutia Also Advance - Nasdaq
Elutia reports 16% revenue growth, advances breast reconstruction product By Investing.com - Investing.com Canada
Elutia reports 16% revenue growth, advances breast reconstruction product - Investing.com
Elutia (ELUT) Strengthens Position with Drug-Eluting Platform - GuruFocus
Elutia reports preliminary fourth quarter 2025 results, strengthened financial position, and upcoming Nxt-41X milestones - marketscreener.com
Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, And Upcoming Nxt-41X Milestones - TradingView — Track All Markets
Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones - The Manila Times
Press Release: Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones - 富途资讯
Elutia, Inc.Class A Common Stock (NQ: ELUT - FinancialContent
Elutia (NASDAQ:ELUT) Shares Up 4.7% – Should You Buy? - Defense World
Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery - manilatimes.net
Elutia Inc. to Highlight NXT-41x Program at Inaugural Global BioInnovation Forum during JP Morgan Healthcare Conference - Quiver Quantitative
Breast reconstruction infections hit 25% of patients. A new approach emerges - Stock Titan
Why Elutia Inc. stock attracts high net worth investorsWeekly Profit Recap & Safe Entry Zone Tips - ulpravda.ru
Why Elutia Inc. stock could rally in 2025Weekly Volume Report & Weekly Momentum Stock Picks - Улправда
How Elutia Inc. stock reacts to job market dataMarket Volume Summary & Daily Risk Controlled Trade Plans - Улправда
Will Elutia Inc. stock gain from strong economy2025 Price Momentum & Daily Chart Pattern Signal Reports - ulpravda.ru
About Us | Oil & Gas JournalElutia, Inc.Class A Common Stock (Nasdaq:ELUT) Stock Quote - FinancialContent
Elutia Inc (ELUT) upgraded to buy: Here's what you should know - MSN
Gaithersburg biotech Elutia battles to keep Nasdaq listing after asset sale - The Business Journals
Where Analysts See Viviana Power Tech Limited Stock by YearEndTechnical Analysis Insights & Small Investment Growth Plans - earlytimes.in
Elutia Faces Nasdaq Noncompliance, Considers Options to Regain Listing - The Globe and Mail
Earnings Risk: Why Elutia Inc stock attracts high net worth investorsBond Market & Breakout Confirmation Alerts - moha.gov.vn
Elutia receives Nasdaq notice for non-compliance with market value and bid price rules - Investing.com India
Elutia Received Notice of Noncompliance - TradingView — Track All Markets
Elutia faces Nasdaq noncompliance, considers options to regain listing - MSN
Elutia Inc (ELUT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.33%
0.51%
자본화:
|
볼륨(24시간):